West Pharmaceutical Services, Inc. (WST) Q2 2023 Earnings Call Transcript

West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2023 Earnings Conference Call July 27, 2023 9:00 AM ET

Company Participants

Quintin Lai - Vice President of Investor Relations
Eric Green - President & Chief Executive Officer
Bernard Birkett - Senior Vice President and Chief Financial & Operations Officer

Conference Call Participants

Larry Solow - CJS
Jacob Johnson - Stephens
Paul Knight - KeyBanc
Derik De Bruin - Bank of America
Matthew Larew - William Blair
David Windley - Jefferies
John Sourbeer - UBS
Justin Bowers - Deutsche Bank

Operator

Thank you for standing by, and welcome to the West Pharmaceutical Services Q2 2023 Earnings Conference Call. [Operator Instructions] Please be advised today's conference call is being recorded. I would now like to turn the call over to Mr. Quintin Lai, Vice President of Investor Relations. Please go ahead.

Quintin Lai

Thank you, Valerie. Good morning, and welcome to West's Second Quarter 2023 Conference Call. We issued our financial results this morning and the release has been posted in the Investors section on the company's website located at westpharma.com. This morning, Eric Green and Bernard Birkett will review our financial results, provide an update on our business and present an update on our financial outlook for the full year 2023. There's a slide presentation that accompanies today's call, and a copy of that presentation is available on the Investors section of our website. On Slide 4, is our Safe Harbor statement. Statements made by management on this call and in the accompanying presentation contain forward-looking statements within the meaning of U.S. federal securities laws. These statements are based on our beliefs and assumptions, current expectations, estimates and forecasts. The company's future results are influenced by many factors beyond the control of the company. Actual results could differ materially from past results as well as those expressed or implied in any forward-looking statement made here. Please refer to today's press release as well